Funding Opportunity Announcement (FOA) Number: RFA-AG-19-011
This announcement invites the submission of a single cooperative agreement and phased innovation UH2/UH3 to identify omics profiles associated with protection against multiple aging conditions and with exceptional health span and refine strategies for utilising these profiles in therapeutics development.
Funding & Duration
Application budgets should not exceed USD $3.3M (approx. AUD $4.5M) in direct costs.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Dates
- 14 October 2018 – Letter of Intent (LOI) via Grants.Gov submission portal.
- 31 October 2018 – full applications submitted for internal review.
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review